Papers - YONEYAMA Tohru
-
Effects of six-cycle completion and earlier use of radium-223 therapy on prognosis for metastatic castration-resistant prostate cancer: A real-world multicenter retrospective study.
Sasaki D, Hatakeyama S, Kawaguchi H, Hatayama Y, Ishibashi Y, Kusaka A, Noro D, Tanaka T, Ito H, Okuyama Y, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Aoki M, Ohyama C
Urologic oncology 40 ( 2 ) 64.e1 - 64.e8 2022.2
-
フレイルと合併症は限局性前立腺癌の治療選択に関与する因子である
小玉 寛健, 畠山 真吾, 岡本 哲平, 米山 徹, 山本 勇人, 米山 高弘, 橋本 安弘, 大山 力
日本泌尿器科学会総会 109回 PP33 - 04 2021.12
-
イムノグロブリンN-glycan signatureによる尿路上皮癌の診断法
小玉 寛健, 米山 徹, 田中 壽和, 野呂 大輔, 飛澤 悠葵, 山本 勇人, 須藤 晋一郎, 畠山 真吾, 米山 高弘, 橋本 安弘, 柿崎 育子, 中路 重之, 大山 力
日本泌尿器科学会総会 109回 AOP07 - 01 2021.12
-
Simultaneous analysis of serum a 2,3-linked sialylation and core-type fucosylation of PSA for the detection of clinically significant prostate cancer(和訳中)
波多野 浩士, 米山 徹, 畠山 真吾, 藤田 和利, 三善 英知, 吉村 一宏, 植村 天受, 大山 力, 野々村 祝夫
日本泌尿器科学会総会 109回 ISP02 - 03 2021.12
-
Simultaneous analysis of serum α2,3-linked sialylation and core-type fucosylation of prostate-specific antigen for the detection of high-grade prostate cancer.
Koji Hatano, Tohru Yoneyama, Shingo Hatakeyama, Eisuke Tomiyama, Mutsumi Tsuchiya, Mitsuhisa Nishimoto, Kazuhiro Yoshimura, Eiji Miyoshi, Hirotsugu Uemura, Chikara Ohyama, Norio Nonomura, Kazutoshi Fujita
British journal of cancer 126 ( 5 ) 764 - 770 2021.11
-
Utility of total cell-free DNA levels for surgical damage evaluation in patients with urological surgeries.
Sakae Konishi, Takuma Narita, Shingo Hatakeyama, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Yuki Tobisawa, Daisuke Noro, Tendo Sato, Kyo Togashi, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Scientific reports 11 ( 1 ) 22103 - 22103 2021.11
-
高リスク上部尿路上皮癌への術前化学療法と腫瘍学的転帰の傾向 多施設後ろ向き研究
濱谷 智子, 畠山 真吾, 田中 壽和, 久保田 優花, 富樫 赳, 細越 正吾, 藤田 尚紀, 日下 歩, 得居 範子, 岡本 哲平, 山本 勇人, 米山 徹, 米山 高弘, 橋本 安弘, 大山 力
日本癌治療学会学術集会抄録集 59回 O22 - 1 2021.10
-
血清イムノグロブリンN-glycan signatureによる尿路上皮癌の診断法
小玉 寛健, 米山 徹, 田中 壽和, 野呂 大輔, 須藤 晋一郎, 飛澤 悠葵, 山本 勇人, 畠山 真吾, 米山 高弘, 橋本 安弘, 柿崎 育子, 中路 重之, 大山 力
日本癌治療学会学術集会抄録集 59回 O18 - 3 2021.10
-
Characteristics of α2,3-sialyl N-glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level.
Tohru Yoneyama, Hayato Yamamoto, Mihoko Sutoh Yoneyama, Yuki Tobisawa, Shingo Hatakeyama, Takuma Narita, Hirotake Kodama, Masaki Momota, Hiroyuki Ito, Shintaro Narita, Fumiyasu Tsushima, Koji Mitsuzuka, Takahiro Yoneyama, Yasuhiro Hashimoto, Wilhelmina Duivenvoorden, Jehonathan H Pinthus, Shingo Kakeda, Akihiro Ito, Norihiko Tsuchiya, Tomonori Habuchi, Chikara Ohyama
The Prostate 81 ( 16 ) 1411 - 1427 2021.9
-
Comparison of pembrolizumab with conventional chemotherapy after first-line platinum-based chemotherapy for advanced urothelial carcinoma in real-world practice: A multicenter retrospective study.
Takuma Narita, Shingo Hatakeyama, Kazuyuki Numakura, Mizuki Kobayashi, Yumina Muto, Mitsuru Saito, Shintaro Narita, Toshikazu Tanaka, Daisuke Noro, Noriko Tokui, Takahiro Yoneyama, Yasuhiro Hashimoto, Tomonori Habuchi, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 28 ( 9 ) 899 - 905 2021.9
-
腎臓結石形成に関与する糖鎖変異オステオポンチンの同定
阿南 剛, 米山 徹, 畠山 真吾, 米山 高弘, 橋本 安弘, 佐藤 信, 大山 力
日本腎臓学会誌 63 ( 4 ) 447 - 447 2021.6
-
The effect of number of treatment cycles of platinum-based first-line chemotherapy on maximum radiological response in patients with advanced urothelial carcinoma.
Kazutaka Okita, Shingo Hatakeyama, Kazuhisa Hagiwara, Yuichiro Suzuki, Toshikazu Tanaka, Daisuke Noro, Noriko Tokui, Naoki Fujita, Sakae Konishi, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Urologic oncology 39 ( 12 ) 832.e17 - 832.e23 2021.4
-
Narrative review of urinary glycan biomarkers in prostate cancer.
Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Hayato Yamamoto, Chikara Ohyama
Translational andrology and urology 10 ( 4 ) 1850 - 1864 2021.4
-
Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer.
Hirotaka Horiguchi, Shingo Hatakeyama, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Toshikazu Tanaka, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Tadashi Yoshizawa, Yasuhiro Hashimoto, Toshiaki Kawaguchi, Chikara Ohyama
Urologic oncology 39 ( 4 ) 238.e9-238.e17 - 238.e17 2021.4
-
Non-maintenance intravesical Bacillus Calmette-Guérin induction therapy with eight doses in patients with high- or highest-risk non-muscle invasive bladder cancer: a retrospective non-randomized comparative study.
Miyake M, Iida K, Nishimura N, Miyamoto T, Fujimoto K, Tomida R, Matsumoto K, Numakura K, Inokuchi J, Morizane S, Yoneyama T, Matsumura Y, Abe T, Inoue M, Yamada T, Terada N, Hirao S, Uemura M, Matsushita Y, Taoka R, Kobayashi T, Kojima T, Matsui Y, Kitamura H, Nishiyama H, Japanese Urological Oncology Group
BMC cancer 21 ( 1 ) 266 2021.3
-
Prognostic significance of total plasma cell-free DNA level and androgen receptor amplification in castration-resistant prostate cancer.
Yuka Kubota, Shingo Hatakeyama, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Itsuto Hamano, Sakae Konishi, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
World journal of urology 39 ( 9 ) 3265 - 3271 2021.3
-
Effect of frailty and comorbidity on surgical contraindication in patients with localized prostate cancer (FRART-PC Study).
Hirotake Kodama, Shingo Hatakeyama, Masaki Momota, Kyo Togashi, Tomoko Hamaya, Itsuto Hamano, Naoki Fujita, Yuta Kojima, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Kazuaki Yoshikawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Urologic oncology 39 ( 3 ) 191.e1-191.e8 - 191.e8 2021.3
-
Ghrelin after chemotherapy as a prognostic predictor of progression-free survival in patients with muscle-invasive bladder cancer.
Masayuki Tomioka, Tohru Yoneyama, Yuki Tobisawa, Kota Kawase, Chie Nakai, Manabu Takai, Daiki Kato, Koji Iinuma, Keita Nakane, Kosuke Mizutani, Yasuhiro Hashimoto, Takuya Koie
Translational andrology and urology 10 ( 3 ) 1192 - 1201 2021.3
-
The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study).
Kyo Togashi, Shingo Hatakeyama, Yuta Kojima, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Itsuto Hamano, Tomoko Hamaya, Naoki Fujita, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Urologic oncology 39 ( 3 ) 192.e7-192.e14 - 192.e14 2021.3
-
Relationship of frailty with treatment modality selection in patients with muscle-invasive bladder cancer (FRART-BC study).
Hiromichi Iwamura, Shingo Hatakeyama, Masaki Momota, Yuta Kojima, Takuma Narita, Teppei Okamoto, Naoki Fujita, Itsuto Hamano, Kyou Togashi, Tomoko Hamaya, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Translational andrology and urology 10 ( 3 ) 1143 - 1151 2021.3